Get Premium to unlock powerful stock data
Adaptive Biotechnologies Corp logo

Adaptive Biotechnologies Corp

$ 8.22 +0.65 (+8.59%) 10:08 PM EST
P/E:
At Loss
P/B:
2.11
Market Cap:
$ 1.17B
Enterprise V:
$ 919.08M
Volume:
1.15M
Avg Vol (2M):
1.49M
Also Trade In:
Volume:
1.15M
Market Cap $:
1.17B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.49M
Enterprise Value $:
919.08M
PB Ratio:
2.11
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Adaptive Biotechnologies Corp
NAICS : 325412 SIC : 2836
1551 Eastlake Avenue East, Suite 200, Seattle, WA, USA, 98102
Description
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Name Current Vs Industry Vs History
Cash-To-Debt 3.2
Equity-to-Asset 0.65
Debt-to-Equity 0.21
Debt-to-EBITDA -0.53
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.75
Distress
Grey
Safe
Beneish M-Score -2.15
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 66.38
9-Day RSI 53.79
14-Day RSI 47.01
6-1 Month Momentum % -69.74
12-1 Month Momentum % -77.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.64
Quick Ratio 3.46
Cash Ratio 3.16
Days Inventory 131.44
Days Sales Outstanding 42.98
Days Payable 40.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.3

Financials (Next Earnings Date:2022-08-04 Est.)

ADPT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ADPT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 154.522
EPS (TTM) ($) -1.62
Beta 0
Volatility % 54.52
14-Day RSI 47.01
14-Day ATR ($) 0.713401
20-Day SMA ($) 7.90075
12-1 Month Momentum % -77.5
52-Week Range ($) 6.2 - 43.3968
Shares Outstanding (Mil) 142.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Adaptive Biotechnologies Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More